US 10004783
Method for delivering pramlintide into a lumen of the intestinal tract using a swallowable drug delivery device
granted A61KA61K31/155A61K38/22
Quick answer
US patent 10004783 (Method for delivering pramlintide into a lumen of the intestinal tract using a swallowable drug delivery device) held by Rani Therapeutics, LLC expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rani Therapeutics, LLC
- Grant date
- Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/155, A61K38/22, A61K38/26, A61K38/28